ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1095

Metal Concentrations in Patients with Failed Metal-On-Metal Hip Prostheses Determine the Inflammatory Phenotype in Peri-Implant Tissue

Erja-Leena Paukkeri1, Riku Korhonen1, Antti Eskelinen2, Marko Pesu3, Kaija Vasama4, Teemu Moilanen2 and Eeva Moilanen1, 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland, 2Coxa Hospital for Joint Replacement, Tampere, Finland, 3Immunoregulation, Institute of Biomedical Technology, University of Tampere, Tampere, Finland, 4Fimlab Laboratories, Tampere, Finland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Arthroplasty, inflammation and macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Orthopedics, Low Back Pain, and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Hip arthroplasty is the standard treatment of a painful hip destruction in rheumatoid arthritis and osteoarthritis. The use of metal-on-metal (MoM) bearing surfaces in total hip arthroplasty gained popularity especially in young and active patients during the last decade. Recently, worrisome failures due to inflammatory soft tissue reactions related to wear particles have been widely reported. The pathogenesis of this reaction is unknown. The aim of the present study was to clarify the inflammatory responses in peri-implant tissue in patients with a failure of MoM articulation.

Methods:

Sixteen patients with a failed Articular Surface Replacement (ASR) implant were included in the study. Blood metal ion levels were analysed with coupled plasma mass spectrometry before revision surgery. Samples of peri-implant tissues collected during revision surgery were degraded by enzyme digestion and the distributions of cell populations were analysed by flow cytometry.

Results:

In macroscopic observation, peri-implant reactions had variable amounts of necrotic and granulomatous tissue and cystic pseudotumour formation. All patients expressed elevated levels of blood chromium and cobalt, but the patient-to-patient variation was significant. In histological examination, intensive inflammatory cell infiltration was a characteristic feature, but only few metal containing cells were observed. An analysis by flow cytometry showed that the distributions of the inflammatory cells were mainly polarized either to macrophage-rich (CD45+/CD14+) or T-lymphocyte-rich (CD45+/CD3+) phenotypes with the average portions being 54 % (macrophages) and 20 % (T-lymphocytes) in macrophage-dominated inflammation and 25 % (macrophages) and 54 % (T-lymphocytes) in T-lymphocyte-dominated conditions. The portions of B-lymphocytes (CD45+/CD19+) and granulocytes (CD45+/CD15+) were small. Interestingly, the levels of blood chromium and cobalt were significantly higher in patients with macrophage-dominated inflammation than in patients with T-lymphocyte-dominated inflammation.

Conclusion:

The results suggest that the adverse reactions induced by MoM wear particles contain heterogeneous pathogeneses and the metal levels seem to be an important factor in the determination of inflammatory phenotype. The present results support the hypothesis that higher levels of metal particles cause tissue necrosis and macrophages are recruited to clear the necrotic debris. The lymphocyte-dominated inflammation may, on the other hand, reflect a delayed hypersensitivity reaction induced by lower metal concentrations.


Disclosure:

E. L. Paukkeri,
None;

R. Korhonen,
None;

A. Eskelinen,
None;

M. Pesu,
None;

K. Vasama,
None;

T. Moilanen,
None;

E. Moilanen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/metal-concentrations-in-patients-with-failed-metal-on-metal-hip-prostheses-determine-the-inflammatory-phenotype-in-peri-implant-tissue/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology